SCHEMBL2503392

SCHEMBL2503392

COC(=O)NCC1COC(=O)N1c1cc(F)c(N2CCN(C(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
ALK Q9UM73 1/20 0.36
MEN1 O00255 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
F13A1 P00488 1/20 0.35
TGM2 P21980 1/20 0.35
TGM1 P22735 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
MMP14 P50281 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.35
DPP4 P27487 1/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2480116 0.93 ALDH1A1 (0.37) GPR119SMN1; SMN2LMNAMAPTMEN1
SCHEMBL2452755 0.92 MAOA (0.40) GPR119SMN1; SMN2LMNAMAPTALK
SCHEMBL2486343 0.92 GPR119 (0.37) GPR119SMN1; SMN2MEN1CYP2C19KMT2A
SCHEMBL2507043 0.87 GPR119 (0.41) GPR119LMNAMAPTMMP2MMP13
SCHEMBL2480377 0.86 GPR119 (0.40) GPR119LMNAMAPTMMP2MMP13
SCHEMBL2504492 0.85 KDM4E (0.37) GPR119MAPTF13A1TGM2TGM1
SCHEMBL2503390 0.83 MAOB (0.47) LMNAMAOAMAOB
SCHEMBL2499942 0.83 GPR119 (0.39) GPR119F13A1TGM2TGM1
SCHEMBL2480117 0.83 MEN1 (0.41) LMNAMEN1CYP2C19KMT2AMMP13
SCHEMBL2498576 0.82 HPGD (0.39) GPR119SMN1; SMN2LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841306-B2 Antimicrobials PANACEA BIOTEC LTD. (IN) 2014-09-23 US disclosed
US-20110245258-A1 NOVEL ANTIMICROBIALS PANACEA BIOTEC LTD. (IN) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245258-A1 NOVEL ANTIMICROBIALS ECI1, XDH, CYP3A4 GPR119 2490/4885SMN1; SMN2 3935/4885LMNA 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.